Gut microbial pathway identified as target for improved heart disease treatment
Cleveland ClinicCleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease.
Cleveland Clinic researchers have made a significant discovery about how the gut microbiome interacts with cells to cause cardiovascular disease.
Investigators with the Smidt Heart Institute at Cedars-Sinai have developed an artificial intelligence (AI) program to detect the presence and severity of mitral valve regurgitation, the most common heart valve disorder.
A team led by a Children’s Hospital Los Angeles heart surgeon has received a patent for a novel device design that could solve a pressing problem: how to bridge patients with a Fontan circulation to heart transplant.
March 2020 was a scary time for Adam Cardello and Zohra Ahmadi Cardello. It was the start of the COVID-19 pandemic, and their first child, Safaa Cardello, had just been born more than three months prematurely.
En el calor abrasador del verano, cualquier persona que pase tiempo afuera podría beneficiarse de un tejido refrigerante. Pero ahora, los investigadores han innovado con un revestimiento de microescala a base de tiza que enfría el aire debajo del tejido tratado hasta 13 grados Celsius. Presentarán sus resultados en la ACS Fall 2024.
Children born with certain heart defects receive a shunt implant to improve blood flow. The shunt must be replaced as their bodies grow. Researchers say a new light-reactive expandable shunt could cut the number of surgeries these children receive. They will present their results at ACS Fall 2024.
Los niños que nacen con ciertos defectos cardíacos se someten a un implante de shunt para mejorar el flujo sanguíneo. El shunt debe cambiarse a medida que el cuerpo crece. Los investigadores informan que un nuevo shunt expandible que reacciona a la luz podría reducir el número de cirugías a las que se someten estos niños. Presentarán sus resultados en la ACS Fall 2024.
Heart failure is especially fatal for people without access to medical facilities. A research team aims to bring heart failure screening from the lab to the home with a biosensor that uses a drop of saliva to screen for biomarkers of the disease. They will present their results at ACS Fall 2024.
Wearable cuffless blood pressure monitoring is expected to overcome the discomfort caused to patients by commonly used cuff sphygmomanometers in clinical settings. Flexible electronics and machine learning provide new impetus for the development of wearable cuffless blood pressure monitoring, bringing continuous and comfortable blood pressure monitoring to patients.
Mayo Clinic researchers are using artificial intelligence (AI) with an advanced 3D body-volume scanner – originally developed for the clothing industry – to help doctors predict metabolic syndrome risk and severity.
A newly compiled list of foods and drinks commonly consumed in the United States hints at why many adults unknowingly overdo it on saturated fat and added sugar in their daily diet, a new study suggests.
Taghreed Mohammed Al-Turki, PhD, a postdoctoral researcher in the UNC Lineberger lab of Jack Griffith, PhD, describes her long, difficult, and rewarding journey of becoming a telomere scientist as a first-time mother at the University of North Carolina School of Medicine.
Scientists working to uncover the secret behind why exercise improves our reaction time have tested whether electrical muscle stimulation has the same results.
This spring, Children’s Hospital Los Angeles became one of just 15 pediatric hospitals in the country to be designated as a TSC Alliance Center of Excellence—demonstrating the highest level of comprehensive services for diagnosing and managing tuberous sclerosis complex (TSC). CHLA sees more than 120 young patients a year with TSC.
Each year, the American Heart Association recognizes hospitals across the country for consistently following up-to-date, research-based guidelines to ensure all patients have access to lifesaving care.
New Cleveland Clinic and Tufts University research shows that elevated levels of the gut microbiome trimethylamine N-oxide (TMAO) pathway led to a higher risk of heart failure independent of other risk factors, according to a study of two large National Institutes of Health cohorts. The study was recently published in the journal Circulation: Heart Failure.
They’re the dinky digital tools you can download in a few seconds, but despite their literal size, health and fitness apps pack a real punch when it comes to getting results, say researchers at the University of South Australia.
Researchers aim to transform cancer survivorship care in the U.S. by enhancing the adoption of shared delivery models
The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and published in JAMA Cardiology.
Cardiólogos de la Clínica de Ritmo Cardíaco de Mayo Clinic están utilizando una nueva fuente de energía innovadora para tratar de manera segura y exitosa un tipo común de arritmia cardíaca. La terapia, llamada ablación por campo pulsado (PFA), ha recibido la aprobación de la Administración de Alimentos y Medicamentos (FDA) y representa un hito importante en el tratamiento de fibrilación auricular (FA).